Genlink Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 15-07-2024
- Paid Up Capital ₹ 0.10 M
as on 15-07-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 52.41 Cr
as on 15-07-2024
- Revenue 5.45%
(FY 2021)
- Profit -3.01%
(FY 2021)
- Ebitda -7.73%
(FY 2021)
- Net Worth 13.80%
(FY 2021)
- Total Assets 1.88%
(FY 2021)
About Genlink Pharma Solutions
The Corporate was formerly known as Genlink Pharmaserv Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹52.41 Cr.
The Key Managerial Personnel (KMP) at Genlink Pharma Solutions Private Limited India is Chaitali Gawkar as COMPANY SECRETARY. Anand Shah, Susheel Koul, Sumit Gupta, and One other member serve as directors at the Company.
- CIN/LLPIN
U74110MH2016PTC280765
- Company No.
280765
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Genlink Pharma Solutions?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susheel Koul  | Managing Director | 06-May-2016 | Current |
| Chaitali Gawkar | Company Secretary | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumit Gupta | Nominee Director | 27-Mar-2017 | Current |
| Anand Shah | Director | 06-May-2016 | Current |
| Avani Shah | Director | 15-Jan-2019 | Current |
Financial Performance and Corporate Structure Insights of Genlink Pharma Solutions.
Genlink Pharma Solutions Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 5.45% increase. The company also saw a slight decrease in profitability, with a 3.01% decrease in profit. The company's net worth Soared by an impressive increase of 13.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genlink Pharma Solutions?
In 2020, Genlink Pharma Solutions had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enaltec Pharma Research Private LimitedActive 19 years 7 monthsAnand Shah and Sumit Gupta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 May 2019 | ₹24.50 Cr | Open |
Axis Bank Limited Creation Date: 16 Nov 2018 | ₹2.91 Cr | Open |
Others Creation Date: 17 Mar 2017 | ₹25.00 Cr | Open |
How Many Employees Work at Genlink Pharma Solutions?
Unlock and access historical data on people associated with Genlink Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genlink Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genlink Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
